1643: Modern Chinese Medicine Group Co., Ltd. - Summary | Jitta

Modern Chinese Medicine Group Co., Ltd.

HKG:1643

Price
HK$2.17
Loss Chance
57.9%
1.13JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
216 / 233
2,249 / 2,517
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (11)
Financial Strength (69)
Return to Shareholders (20)
Competitive Advantage (21)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 190.83% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
1.13
100.00%
4.42
147.26%
3.82
206.93%
Pharmaceuticals
7.55
101.61%
7.84
21.76%
6.59
22.20%
COMPANY DESCRIPTION
Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, kidney invigoration pill, heart wellness capsules, menstrual discomfort relief, liver detox tablets, additional ingredient Huoxiang Zheng Qi pill, liver-dispersing and stomach regulating pills, and fever- removing and detoxification pills. The company offers its products as therapeutics for the treatment of qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and symptoms of COVID-19 and similar illnesses. It also provides business support, technical, and consulting services. The company serves elderlies and middle-aged customers. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.